SCHEMBL8016167

SCHEMBL8016167

CCN(C(=O)Cc1ccccc1)c1cc[c]cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 2/20 0.52
ALDH1A1 P00352 2/20 0.50
GLA P06280 1/20 0.50
TSHR P16473 1/20 0.50
TRPM8 Q7Z2W7 1/20 0.47
TP53 P04637 2/20 0.44
AKR1B1 P15121 1/20 0.44
MLYCD O95822 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
LTB4R2 Q9NPC1 1/20 0.43
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
NCOR2 Q9Y618 1/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4153727 0.89 ALDH1A1 (0.63) CNR2ALDH1A1GLATSHRTRPM8
SCHEMBL8009229 0.86 NPC1 (0.57) CNR2ALDH1A1GLATSHRTRPM8
SCHEMBL6543341 0.83 NPC1 (0.59) CNR2ALDH1A1TRPM8TP53MLYCD
SCHEMBL28021112 0.83 CNR2 (0.57) CNR2ALDH1A1GLATSHRTRPM8
SCHEMBL8012628 0.81 CNR2 (0.56) CNR2ALDH1A1GLATSHRTRPM8
SCHEMBL8012822 0.80 CES1 (0.45) ALDH1A1TRPM8AKR1B1MEN1KMT2A
SCHEMBL2539805 0.80 ALDH1A1 (0.46) ALDH1A1GLATSHRTP53MLYCD
SCHEMBL4152623 0.79 ALDH1A1 (0.56) CNR2ALDH1A1GLATSHRTP53
SCHEMBL8015941 0.79 NPSR1 (0.50) ALDH1A1GLATRPM8AKR1B1MEN1
SCHEMBL3763981 0.78 LTB4R2 (0.56) CNR2ALDH1A1GLALTB4R2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1066729-C Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-06-06 CN disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 US disclosed
US-5886014-A TREATMENT AND/OR PROPHYLAXIS OF A VARIETY OF DISORDERS, INCLUDING HYPERLIPEMIA, HYPERGLYCEMIA, OBESITY, IMPAIRED GLUCOSE TOLERANCE (IGT), INSULIN RESISTANCE AND DIABETIC COMPLICATIONS SANKYO COMPANY, LIMITED (JP) 1999-03-23 US disclosed
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 US disclosed
CN-1157288-A Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1997-08-20 CN disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 EP disclosed